Board & Advisors
The legitimacy layer. Per 7-foundation playbook: “credibility pivot” = recruiting professional governance early.
Board of Directors
HK CLG requires minimum 2 directors + 1 company secretary. One director may also serve as the secretary; a sole-director CLG is not permitted.
Day 1 (incorporation, 2 directors minimum):
- Egor Lyfar — Founding Director + Chairman + Company Secretary
- 2nd Founding Director — TBD before NNC1G filing. Candidates: Vladislava Lyfar; or accelerated independent recruit (finance/legal background).
Year 1 target (3 directors minimum, broader board):
- Egor (founder, chairman)
- 1 independent director — finance/legal background
- 1 independent director — clinical/scientific background
Scientific Advisory Board (SAB)
Confirmed:
- Jeffrey Holt, PhD — Boston Children’s Hospital / Harvard Medical School. Cochlear gene therapy world expert. Verbal yes 2026-03-31. Letter pending → index.
Targets:
- Yilai Shu, MD/PhD — Fudan University, Eye & ENT Hospital of Shanghai. China’s leading cochlear gene therapy clinician. Asian-network anchor.
- 1-2 more SAB members in Year 1 (US-based researcher, clinical geneticist, registry-design expert)
Charters and bylaws
governance/sab-charter.md(to write — 1-pager, term, scope, no-comp, expected ask cadence)governance/board-bylaws.md(to write — derived from HK CLG AoA)governance/coi-policy.md— see Legal & Compliance
Meeting cadence
- Board: minimum quarterly. Minutes filed in
governance/{YYYY-MM-DD}-board-minutes.md. - SAB: semi-annual + ad hoc when reviewing grant applications.
People files
Connections
[part-of]index[applies]index[see-also]Legal & Compliance